These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7581139)

  • 21. Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.
    Fraschini G; Ciociola A; Esparza L; Templeton D; Holmes FA; Walters RS; Hortobagyi GN
    J Clin Oncol; 1991 Jul; 9(7):1268-74. PubMed ID: 1828499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open-label dose comparison study of ondansetron for the prevention of emesis associated with chemotherapy prior to bone marrow transplantation.
    Osowski CL; Dix SP; Lynn M; Davidson T; Cohen L; Miyahara T; Sexauer MC; Joyce R; Yeager A; Wingard JR
    Support Care Cancer; 1998 Nov; 6(6):511-7. PubMed ID: 9833299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical studies with ondansetron in the control of radiation-induced emesis.
    Priestman TJ
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 1():S29-33. PubMed ID: 2533896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy.
    Tsavaris NB; Koufos C; Katsikas M; Dimitrakopoulos A; Athanasiou E; Linardaki G
    J Pain Symptom Manage; 1999 Sep; 18(3):218-22. PubMed ID: 10517044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis.
    Belkacémi Y; Ozsahin M; Pène F; Rio B; Sutton L; Laporte JP; Touboul E; Gorin NC; Laugier A
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):77-82. PubMed ID: 8823261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of oral ondansetron in the prevention of emesis in outpatients receiving cyclophosphamide-based chemotherapy. The Ondansetron Study Group.
    Beck TM; Ciociola AA; Jones SE; Harvey WH; Tchekmedyian NS; Chang A; Galvin D; Hart NE
    Ann Intern Med; 1993 Mar; 118(6):407-13. PubMed ID: 8439113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group.
    Sussman G; Shurman J; Creed MR; Larsen LS; Ferrer-Brechner T; Noll D; Allegra J; Montgomery R; Schreck D; Grafstein E; Ramalanjaona G; Patel V; Ducharme J; Ortenwall P; Foster E; Ames M
    Clin Ther; 1999 Jul; 21(7):1216-27. PubMed ID: 10463519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiemetic therapy for high-dose chemotherapy with transplantation: report of a retrospective analysis of a 5-HT(3) regimen and literature review.
    Perez EA; Tiemeier T; Solberg LA
    Support Care Cancer; 1999 Nov; 7(6):413-24. PubMed ID: 10541984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation.
    Barbounis V; Koumakis G; Vassilomanolakis M; Hatzichristou H; Tsousis S; Efremidis AP
    Support Care Cancer; 1995 Sep; 3(5):301-6. PubMed ID: 8520876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tropisetron versus ondansetron in the prevention and control of emesis in patients undergoing chemotherapy with FAC/FEC for metastatic or surgically treated breast carcinoma].
    Campora E; Simoni C; Rosso R
    Minerva Med; 1994; 85(1-2):25-31. PubMed ID: 8152575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aprepitant pharmacokinetics and assessing the impact of aprepitant on cyclophosphamide metabolism in cancer patients undergoing hematopoietic stem cell transplantation.
    Bubalo JS; Cherala G; McCune JS; Munar MY; Tse S; Maziarz R
    J Clin Pharmacol; 2012 Apr; 52(4):586-94. PubMed ID: 21415280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ondansetron versus chlorpromazine for preventing emesis in bone marrow transplant recipients: a double-blind randomized study.
    Bosi A; Guidi S; Messori A; Saccardi R; Lombardini L; Vannucchi AM; Fanci R; Rossi-Ferrini P
    J Chemother; 1993 Jun; 5(3):191-6. PubMed ID: 8371129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective emetic control during conditioning of children for bone marrow transplantation using ondansetron, a 5-HT3 antagonist.
    Hewitt M; Cornish J; Pamphilon D; Oakhill A
    Bone Marrow Transplant; 1991 Jun; 7(6):431-3. PubMed ID: 1831395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized double-blinded comparison of the antiemetic efficacy of ondansetron and droperidol in patients receiving high-dose interleukin-2.
    Kim H; Rosenberg SA; Steinberg SM; Cole DJ; Weber JS
    J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):60-5. PubMed ID: 8081560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of ondansetron in pediatric patients undergoing bone marrow transplantation.
    Nahata MC; Hui LN; Koepke J
    Clin Ther; 1996; 18(3):466-76. PubMed ID: 8829022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical safety of ondansetron.
    Bryson JC
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):26-32. PubMed ID: 1485179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Most effective route of administration and utilization of high-dose chemotherapy with bone marrow transplantation in rats.
    Mizushima Y; Morikage T; Sasaki K; Yano S
    Cancer Res; 1989 May; 49(10):2561-6. PubMed ID: 2653619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ondansetron for acute gastroenteritis in children.
    Mehta S; Goldman RD
    Can Fam Physician; 2006 Nov; 52(11):1397-8. PubMed ID: 17279195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation.
    Tiley C; Powles R; Catalano J; Treleaven J; Eshelby J; Hewetson M; Tait D; Cunningham D
    Leuk Lymphoma; 1992 Jul; 7(4):317-21. PubMed ID: 1493431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiemetic efficacy of alprazolam in carboplatin-induced emesis.
    Tsavaris N; Tsoutsos H; Bacoyannis C; Mylonakis N; Karvounis N; Kozatsani-Halividi D; Tsaroucha-Noutsou E; Klinaki A; Kosmidis P
    Chemotherapy; 1991; 37(5):364-70. PubMed ID: 1804597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.